Heart Disease Hypertension Preserved Ejection Fraction 
DAIC
JUNE 4, 2024
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment 5. Scientists Suggest a New Method for Diagnosing Heart Diseases 6. Weight Loss Drug Linked with Reduced Need for Diuretics in Heart Failure Patients 7. Tenax Therapeutics Announces New U.S.
Dr. S. Venkatesan MD
APRIL 18, 2024
Lowering the raised LA mean pressure is a major therapeutic goal in any severely symptomatic left heart disease, whether it is valvular or myocardial disease. Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial.
DAIC
FEBRUARY 29, 2024
24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m.
DAIC
JUNE 26, 2024
The analysis sought to determine whether phenotypic features and treatment effects of semaglutide vary by sex in obesity-related heart failure ( HF ) with preserved ejection fraction (HFpEF). Our study sheds light on these differences and the consistent benefits of semaglutide for women and men.”
Cardiometabolic Health Congress
JULY 25, 2023
There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity and cachexia.”
Journal of the American Heart Association
MARCH 13, 2025
The risk of allcause and noncardiovascular mortality and first allcause hospitalization was higher with EF values >55% in crude but not adjusted analyses.ConclusionsAmong patients with HF with preserved EF, 21% had EF 60%.
Expert insights. Personalized for you.
105 
Let's personalize your content